---
title: "Advanced Biomed Secures New Short-Term Unsecured Loan Financing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282746718.md"
description: "Advanced Biomed Inc. has secured a short-term unsecured loan of $600,000 from lender Jie Wang, with a 10% annual interest rate and a six-month term. The company can extend the loan for an additional six months by mutual consent and plans to use the funds to support its operations. This financing reflects the company's reliance on short-term borrowing to maintain liquidity. The loan is governed by New York law, indicating a conventional structure for this financing arrangement. Advanced Biomed operates in the biomedical sector, focusing on operational continuity."
datetime: "2026-04-14T21:17:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282746718.md)
  - [en](https://longbridge.com/en/news/282746718.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282746718.md)
---

# Advanced Biomed Secures New Short-Term Unsecured Loan Financing

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Advanced Biomed Inc. ( (ADVB) ) is now available.

On April 13, 2026, Advanced Biomed Inc. entered into a loan agreement with lender Jie Wang for an unsecured U.S.$600,000 facility bearing 10% annual interest, with a six-month term from the disbursement date and an option to extend for an additional six months by mutual written consent. The company can prepay the loan without penalty, must repay principal plus accrued interest by maturity, and plans to use the proceeds to fund its operations, underscoring its near-term financing needs and reliance on short-term borrowing to support business activities.

The loan is governed by New York law, with any disputes to be resolved in New York courts, providing a standard legal framework for enforcement and signaling a conventional structure for this insider-style financing arrangement. For stakeholders, the transaction reflects a tactical move to shore up working capital without pledging collateral, balancing liquidity support against higher borrowing costs and refinancing risk at maturity.

**More about Advanced Biomed Inc.**

Advanced Biomed Inc. operates in the biomedical sector, though the company’s specific products and services were not detailed in the filing. The firm appears to be focused on maintaining operational continuity and liquidity, as evidenced by its use of debt financing to support ongoing operations rather than funding a specific project or acquisition.

**Average Trading Volume:** 491,795

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $9.01M

For an in-depth examination of ADVB stock, go to TipRanks’ Overview page.

### Related Stocks

- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)

## Related News & Research

- [Advanced Biomed Completes AI Acquisition and Leadership Transition](https://longbridge.com/en/news/284946343.md)
- [Advanced Biomed Inc. SEC 10-Q Report](https://longbridge.com/en/news/275947350.md)
- [Gotransverse Launches New BI & Analytics Solution to Deliver Real-Time Monetization Intelligence](https://longbridge.com/en/news/286928959.md)
- [08:37 ETDresner Advisory Services Publishes 15th Edition Self-Service Business Intelligence Market Study](https://longbridge.com/en/news/286772174.md)
- [UPI changed how India pays; it can drive the future of borrowing](https://longbridge.com/en/news/286677065.md)